Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)

NCT00863460 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT00863460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00863460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)
Lead sponsor
Institut Curie
Phase
Phase 2
Overall status
Unknown status
Start date
October 3, 2008
Completion date
May 31, 2026
Enrollment
140 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

primary central nervous system lymphoma